BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17383829)

  • 1. Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up.
    Dragun AE; Harper JL; Jenrette JM; Sinha D; Cole DJ
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):354-8. PubMed ID: 17383829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence.
    Trombetta M; Hall M; Julian TB
    Brachytherapy; 2014; 13(5):488-92. PubMed ID: 24950822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial.
    Goyal S; Khan AJ; Vicini F; Beitsch PD; Lyden M; Keisch M; Haffty BG
    Ann Surg Oncol; 2009 Sep; 16(9):2450-8. PubMed ID: 19517191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
    Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
    Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
    Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent Long-term Breast Preservation Rate After Accelerated Partial Breast Irradiation Using a Balloon Device.
    Mann JM; Osian AD; Brandmaier A; Yan W; Sung KJ; Siegel B; Fink S; Kaplan B; Fulman M; Wu G; Christos P; Nori D; Ravi A
    Clin Breast Cancer; 2016 Jun; 16(3):217-22. PubMed ID: 26948247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity.
    Vargo JA; Verma V; Kim H; Kalash R; Heron DE; Johnson R; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):285-91. PubMed ID: 24268787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective multicenter trial evaluating balloon-catheter partial-breast irradiation for ductal carcinoma in situ.
    Abbott AM; Portschy PR; Lee C; Le CT; Han LK; Washington T; Kinney M; Bretzke M; Tuttle TM
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):494-8. PubMed ID: 24074922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy.
    Vicini FA; Keisch M; Shah C; Goyal S; Khan AJ; Beitsch PD; Lyden M; Haffty BG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):512-8. PubMed ID: 22079730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy.
    Watkins JM; Harper JL; Dragun AE; Ashenafi MS; Sinha D; Li J; Cole DJ; Jenrette JM
    Brachytherapy; 2008; 7(4):305-9. PubMed ID: 18778970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-institutional study of feasibility, implementation, and early clinical results with noninvasive breast brachytherapy for tumor bed boost.
    Hamid S; Rocchio K; Arthur D; Vera R; Sha S; Jolly M; Cavanaugh S; Wooten E; Benda R; Greenfield B; Prestidge B; Ackerman S; Kuske R; Quiet C; Snyder M; Wazer DE
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1374-80. PubMed ID: 22209153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 2 Trial of Accelerated Partial Breast Irradiation (APBI) Using Noninvasive Image Guided Breast Brachytherapy (NIBB).
    Hepel JT; Leonard KL; Sha S; Graves TA; Wiggins DL; Mastras D; Pittier A; ; Wazer DE
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1143-1149. PubMed ID: 32721422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.
    Vicini FA; Beitsch PD; Quiet CA; Keleher A; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer H; Whitacre EB; Whitworth PW; Fine RE; Haffty BG; Arrambide LS
    Cancer; 2005 Sep; 104(6):1138-48. PubMed ID: 16088962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated partial breast irradiation for pure ductal carcinoma in situ.
    Park SS; Grills IS; Chen PY; Kestin LL; Ghilezan MI; Wallace M; Martinez AM; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):403-8. PubMed ID: 20800374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.
    Richards GM; Berson AM; Rescigno J; Sanghavi S; Siegel B; Axelrod D; Bernik S; Scarpinato V; Mills C
    Ann Surg Oncol; 2004 Aug; 11(8):739-46. PubMed ID: 15249336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.